Low, But Rising PSA--Wait for Imaging or Act Now?
I watched the entire PCRI conference on 4/25 (https://pcri.org), with two well-known experts: Dr. Epstein (Pathology) and Dr. Kwon (Relapse). Both were very relevant to my situation: 72 years old; RALP on 9/22/25; PSA on 12/30: < .01 (standard); PSA on 4/15: 0.171 (ultra sensitive) (next test on 5/4 to determine trend). My "bad news" and "good news" data are below. I have appointments at Johns Hopkins and MSK in NYC to get their recommendations on next steps.
Dr. Epstein emphasized the greater likelihood of BCR and worse outcomes if Cribriform is present, as this group had discussed before. But he emphasized Intraductal Carcinoma (IDC) as even more important (and flat out said a patient should get a BRAC2 test if he has IDC, which I am scheduling).
Dr. Kwon made a strong case for waiting for imaging results before moving ahead with salvage RT and/or hormone therapy. He argued that in relapse cases prostate cancer frequently does not start in the prostate/pelvic area and spread from there but it can be anywhere in your body and shooting radiation “blind” to the pelvic area carries significant risks. He also cited 3 studies showing better outcomes by waiting for imaging results before proceeding (at 3:54:10). Subsequent Q and A near the end with Dr. Scholz emphasized the value of MR imaging in these situations and how under-utilized it is.
I have emailed Dr Kwon to ask if his general approach still applies to someone like me with a lot of high risk factors (see below), but haven't heard back yet. As this group has discussed, studies show better outcomes in high risk cases by starting treatment with lower PSAs (and thus not waiting for cancer growth large enough to be seen on imaging). I looked at 2 of the 3 studies and didnt see discussion of this issue. I will let you know if I get a response.
"Bad News":
GL 7 (4+3)
IDC
Cribriform
EPE
.89 Decipher score
"Good News":
Clean margins, lymph nodes, seminal vesicles during surgery
Clean CPMSA PET scan on 8/25/25 (pre-surgery)
Interested in more discussions like this? Go to the Prostate Cancer Support Group.
Connect

Not every cancer is the same - for HIGH risk PC established practice is to treat early :
https://www.cancernetwork.com/view/psa-cut-point-indicates-when-to-start-salvage-radiotherapy-in-prostate-cancer
-
Like -
Helpful -
Hug
5 Reactions@clevelandguy
This does answer that question for advanced cases, waiting is not the answer
Life expectancy for prostate cancer patients that ignore treatment
https://www.urotoday.com/recent-abstracts/urologic-oncology/prostate-cancer/168250-natural-history-of-untreated-prostate-cancer-a-comprehensive-review-of-long-term-progression-patterns-and-survival-outcomes-beyond-the-abstract.html
Grade Group 1 (Gleason 6) disease showed metastatic progression rates below 5% over 15–20 years and prostate cancer-specific mortality under 5% at two decades. These are the patients for whom active surveillance was designed, and this review provides robust quantitative backing for that approach. Conversely, Grade Groups 4–5 (Gleason 8–10) were uniformly lethal in conservatively managed cohorts: median time to metastasis was 3–5 years for Gleason 8 and just 1–3 years for Gleason 9–10, underscoring the urgency of early intervention for these men.
The intermediate grades deserve particular attention. The distinction between Gleason 3+4 and 4+3—both classified as "Grade Group 2–3" and both often lumped together as "intermediate risk"—carries meaningful clinical weight. Our synthesis found roughly 2–3 fold differences in 15-year progression rates (35% vs. 55%) and hazard ratios for cancer-specific death of 2.1–3.2 between these two patterns. Clinicians and patients should not treat these as equivalent.
-
Like -
Helpful -
Hug
5 Reactions@clevelandguy
Between 20 and 40% of the people that have prostatectomy have a reoccurrence. In the majority of those cases, no metastasis is found.
The American Society of clinical oncologist does not agree with you.
From Ascopubs about what PSA to do salvage radiation.
≤0.2 ng/mL: Starting at this level maximizes disease control and long-term survival. Patients treated at PSA < 0.2 ng/mL achieve higher rates of undetectable post-SRT PSA (56-70%) and improved 5-year progression-free survival (62.7-75%). Delaying SRT beyond PSA ≥0.25 ng/mL increases mortality risk by ~50%.
0.2–0.5 ng/mL: Still effective, particularly for patients with low-risk features (e.g., Gleason ≤7, slow PSA doubling time). The Journal of Clinical Oncology recommends SRT before PSA exceeds 0.25 ng/mL to preserve curative potential.
0.5–1.0 ng/mL: Salvage radiation remains beneficial but may require combining with androgen deprivation therapy (ADT) for higher-risk cases.
This article discusses the above;
https://ascopost.com/news/march-2023/psa-level-at-time-of-salvage-radiation-therapy-after-radical-prostatectomy-and-risk-of-all-cause-mortality/
-
Like -
Helpful -
Hug
6 Reactions@jeffmarc
Very simple, you look at what the experts say, talk with your doctor team and then you make a decision. It just makes sense to me to radiate an area that has detectable cancer vs radiating an area that could have cancer. My choice, you might choose differently.
-
Like -
Helpful -
Hug
1 Reaction@clevelandguy NO, it’s a 65% chance that cancer IS there…Even Dr Kwon, whom I do not agree with, says that SRT fails in ONE THIRD of all cases - so roughly 35%.
So the odds of cancer being in the pelvis are pretty high…
Phil
@heavyphil
Again it’s my choice to radiate my bladder and colon with no medical scan evidence if I don’t want to. I will wait til it shows up on a scan. I know there is a chance cancer is present in very minute qty that does not show up on a scan. When Pca spreads it can also spread to your hips,ribs,shoulders ect. You just don’t radiate the entire body you wait til it shows up on a Pet scan then you radiate it. I like that approach👍.
Dave 3+4
-
Like -
Helpful -
Hug
1 ReactionThanks again for the input. I have decided that I want to get "treatment" as soon as possible and have asked for a PSMA-PET scan as soon as possible.
I am wondering why Dr. Nagur was so reticent to give his opinion and why, when pushed, he recommended a standard/basic treatment course (Orgovyx for 6 months and an unspecified course of radiation), when I don't have a "standard case" (I have IDC, Cribriform, EPE, GL 7(4+3)). In terms of urgency, he just said get the radiation done during the 6 month window of ADT.
My appointment with Dr. Greco at JH (where I will be treated) is 5/14. Should I push for hormone therapy right away? Or is the sRT the higher priority ? It will take a few weeks to get the results of the Decipher test on the prostate tissue, the ALTERA, and hopefully a PMSA-PET scan. Thanks as always
-
Like -
Helpful -
Hug
2 Reactions@clevelandguy That is why everyone should get the Prostox test before prostate radiation to see if they fall into the 75% or 7% probability group of having late radiation side effects. Most of what determines who has bad aftereffects is genetics. A lot of the rest is bad targeting. All medical disclosures are written for lawyers by lawyers since non-disclosure even of a 1 in 10000 chance is opening them up for lawsuits (why a ladder is covered with warning stickers now).
-
Like -
Helpful -
Hug
3 Reactions@jim18
The Prostox test would certainly help. Your comment about bad targeting is why I always say get the best doctors+best facilities=the best results.
Dave 3+4
-
Like -
Helpful -
Hug
1 Reaction@bikeman1 There’s a lot of new revised thinking on the role of ADT. It is quite possible that 6 months is the absolute minimum (while getting SRT) and then you are monitored every 3 months for PSA rise.
After all, it IS the radiation that kills the PCa, so if all you need is the weakening effect of ADT during treatment, why sign up for long term ADT?
ADT is not going to kill cancer cells on its own, regardless of where they are, just keep them suppressed. Better to use it during radiation to the bed and pelvic nodes to, at least, help eliminate all the cancer cells there.
Any PSA rise after that indicates that cancer is also someplace else, so in that case you would wait for a PET scan to show it. Best,
Phil
-
Like -
Helpful -
Hug
6 Reactions